尽管有一些机构抛售，HCA医疗保健仍超出盈利预期并上调了2025年指引。 HCA Healthcare beat earnings estimates and raised 2025 guidance, despite some institutional selling.

美国医疗保健公司第二季度的收益为每股6.96美元,超过估计1.32美元,收入为1916亿美元,同比增长9.6%. HCA Healthcare reported second-quarter earnings of $6.96 per share, exceeding estimates by $1.32, and revenue of $19.16 billion, up 9.6% year-over-year. 该公司将其2025年全年收入指导提高到每股27.00至28.00美元。 The company raised its full-year 2025 earnings guidance to $27.00–$28.00 per share. 尽管包括佛罗里达退休系统和韩国投资公司CORP公司在内的一些机构出售,但诸如TD Cowen和Wells Fargo等大公司维持或提升了评级。 Despite some institutional sell-offs, including by Florida Retirement System and Korea Investment CORP, major firms like TD Cowen and Wells Fargo maintained or upgraded their ratings. 股票交易额接近52周的高点,具有协商一致的“收购”评级,目标价格为474.53美元。 The stock, trading near its 52-week high, has a consensus “Moderate Buy” rating and a $474.53 target price. A0.72 季度红利定为12月29日。 A $0.72 quarterly dividend is set for December 29.